Skip to main content
Top
Published in: BMC Nephrology 1/2008

Open Access 01-12-2008 | Research article

Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA)

Authors: Christopher Keller, Ronit Katz, Mary Cushman, Linda F Fried, Michael Shlipak

Published in: BMC Nephrology | Issue 1/2008

Login to get access

Abstract

Background

Prior studies using creatinine-based estimated glomerular filtration rate (eGFR) have found limited associations between kidney function and markers of inflammation. Using eGFR and cystatin C, a novel marker of kidney function, the authors investigated the association of kidney function with multiple biomarkers in a diverse cohort.

Methods

The Multi-Ethnic Study of Atherosclerosis consists of 6,814 participants of white, African-American, Hispanic, and Chinese descent, enrolled from 2000–2002 from six U.S. communities. Measurements at the enrollment visit included serum creatinine, cystatin C, and six inflammatory and procoagulant biomarkers. Creatinine-based eGFR was estimated using the four-variable Modification of Diet in Renal Disease equation, and chronic kidney disease was defined by an eGFR < 60 mL/min/1.73 m2.

Results

Adjusted partial correlations between cystatin C and all biomarkers were statistically significant: C-reactive protein (r = 0.08), interleukin-6 (r = 0.16), tumor necrosis factor-α soluble receptor 1 (TNF-αR1; r = 0.75), intercellular adhesion molecule-1 (r = 0.21), fibrinogen (r = 0.14), and factor VIII (r = 0.11; two-sided p < 0.01 for all). In participants without chronic kidney disease, higher creatinine-based eGFR was associated only with higher TNF-αR1 levels.

Conclusion

In a cohort characterized by ethnic diversity, cystatin C was directly associated with multiple procoagulant and inflammatory markers. Creatinine-based eGFR had similar associations with these biomarkers among subjects with chronic kidney disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, et al: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004, 351 (25): 2599-2610. 10.1056/NEJMoa040967.CrossRefPubMed Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, et al: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004, 351 (25): 2599-2610. 10.1056/NEJMoa040967.CrossRefPubMed
2.
go back to reference Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000, 342 (12): 836-843. 10.1056/NEJM200003233421202.CrossRefPubMed Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000, 342 (12): 836-843. 10.1056/NEJM200003233421202.CrossRefPubMed
3.
go back to reference Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000, 101 (15): 1767-1772.CrossRefPubMed Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000, 101 (15): 1767-1772.CrossRefPubMed
4.
go back to reference Docci D, Bilancioni R, Buscaroli A, Baldrati L, Capponcini C, Mengozzi S, Turci F, Feletti C: Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron. 1990, 56 (4): 364-367.CrossRefPubMed Docci D, Bilancioni R, Buscaroli A, Baldrati L, Capponcini C, Mengozzi S, Turci F, Feletti C: Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron. 1990, 56 (4): 364-367.CrossRefPubMed
5.
go back to reference Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int. 1990, 37 (1): 116-125. 10.1038/ki.1990.16.CrossRefPubMed Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int. 1990, 37 (1): 116-125. 10.1038/ki.1990.16.CrossRefPubMed
6.
go back to reference Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999, 55 (2): 648-658. 10.1046/j.1523-1755.1999.00273.x.CrossRefPubMed Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999, 55 (2): 648-658. 10.1046/j.1523-1755.1999.00273.x.CrossRefPubMed
7.
go back to reference Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002, 17 (9): 1684-1688. 10.1093/ndt/17.9.1684.CrossRefPubMed Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002, 17 (9): 1684-1688. 10.1093/ndt/17.9.1684.CrossRefPubMed
8.
go back to reference Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J: The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004, 140 (1): 9-17.CrossRefPubMed Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J: The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004, 140 (1): 9-17.CrossRefPubMed
9.
go back to reference Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003, 107 (1): 87-92. 10.1161/01.CIR.0000042700.48769.59.CrossRefPubMed Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003, 107 (1): 87-92. 10.1161/01.CIR.0000042700.48769.59.CrossRefPubMed
10.
go back to reference Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000, 36 (1): 29-34. 10.1053/ajkd.2000.8237.CrossRefPubMed Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000, 36 (1): 29-34. 10.1053/ajkd.2000.8237.CrossRefPubMed
11.
go back to reference Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH: Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005, 16 (5): 1404-1412. 10.1681/ASN.2004100854.CrossRefPubMedPubMedCentral Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH: Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005, 16 (5): 1404-1412. 10.1681/ASN.2004100854.CrossRefPubMedPubMedCentral
12.
go back to reference Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H: Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol. 2000, 54 (3): 203-209.PubMed Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H: Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol. 2000, 54 (3): 203-209.PubMed
13.
go back to reference Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005, 67 (6): 2089-2100. 10.1111/j.1523-1755.2005.00365.x.CrossRefPubMed Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005, 67 (6): 2089-2100. 10.1111/j.1523-1755.2005.00365.x.CrossRefPubMed
14.
go back to reference Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004, 141 (12): 929-937.CrossRefPubMed Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004, 141 (12): 929-937.CrossRefPubMed
15.
go back to reference Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007, 71 (3): 239-244. 10.1038/sj.ki.5002042.CrossRefPubMed Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007, 71 (3): 239-244. 10.1038/sj.ki.5002042.CrossRefPubMed
16.
go back to reference Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG: Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant. 2007, 22 (4): 1087-1092. 10.1093/ndt/gfl744.CrossRefPubMedPubMedCentral Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG: Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant. 2007, 22 (4): 1087-1092. 10.1093/ndt/gfl744.CrossRefPubMedPubMedCentral
17.
go back to reference Erlandsen EJ, Randers E, Kristensen JH: Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999, 59 (1): 1-8. 10.1080/00365519950185940.CrossRefPubMed Erlandsen EJ, Randers E, Kristensen JH: Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999, 59 (1): 1-8. 10.1080/00365519950185940.CrossRefPubMed
18.
go back to reference Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139 (2): 137-147.CrossRefPubMed Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139 (2): 137-147.CrossRefPubMed
19.
go back to reference Murthy K, Stevens LA, Stark PC, Levey AS: Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int. 2005, 68 (4): 1884-1887. 10.1111/j.1523-1755.2005.00608.x.CrossRefPubMed Murthy K, Stevens LA, Stark PC, Levey AS: Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation. Kidney Int. 2005, 68 (4): 1884-1887. 10.1111/j.1523-1755.2005.00608.x.CrossRefPubMed
20.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMed
21.
go back to reference Rosen BD, Cushman M, Nasir K, Bluemke DA, Edvardsen T, Fernandes V, Lai S, Tracy RP, Lima JA: Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol. 2007, 49 (5): 594-600. 10.1016/j.jacc.2006.09.040.CrossRefPubMed Rosen BD, Cushman M, Nasir K, Bluemke DA, Edvardsen T, Fernandes V, Lai S, Tracy RP, Lima JA: Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol. 2007, 49 (5): 594-600. 10.1016/j.jacc.2006.09.040.CrossRefPubMed
22.
go back to reference Randers E, Kristensen JH, Erlandsen EJ, Danielsen H: Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest. 1998, 58 (7): 585-592. 10.1080/00365519850186210.CrossRefPubMed Randers E, Kristensen JH, Erlandsen EJ, Danielsen H: Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest. 1998, 58 (7): 585-592. 10.1080/00365519850186210.CrossRefPubMed
23.
go back to reference Curhan G: Cystatin C: a marker of renal function or something more?. Clin Chem. 2005, 51 (2): 293-294. 10.1373/clinchem.2004.044388.CrossRefPubMed Curhan G: Cystatin C: a marker of renal function or something more?. Clin Chem. 2005, 51 (2): 293-294. 10.1373/clinchem.2004.044388.CrossRefPubMed
24.
go back to reference Koenig W, Twardella D, Brenner H, Rothenbacher D: Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem. 2005, 51 (2): 321-327. 10.1373/clinchem.2004.041889.CrossRefPubMed Koenig W, Twardella D, Brenner H, Rothenbacher D: Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem. 2005, 51 (2): 321-327. 10.1373/clinchem.2004.041889.CrossRefPubMed
25.
go back to reference Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004, 65 (4): 1416-1421. 10.1111/j.1523-1755.2004.00517.x.CrossRefPubMed Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004, 65 (4): 1416-1421. 10.1111/j.1523-1755.2004.00517.x.CrossRefPubMed
26.
go back to reference Bemelmans MH, Gouma DJ, Buurman WA: Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine. 1994, 6 (6): 608-615. 10.1016/1043-4666(94)90048-5.CrossRefPubMed Bemelmans MH, Gouma DJ, Buurman WA: Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine. 1994, 6 (6): 608-615. 10.1016/1043-4666(94)90048-5.CrossRefPubMed
27.
go back to reference Castell JV, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T, Heinrich PC: Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem. 1988, 177 (2): 357-361. 10.1111/j.1432-1033.1988.tb14384.x.CrossRefPubMed Castell JV, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T, Heinrich PC: Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem. 1988, 177 (2): 357-361. 10.1111/j.1432-1033.1988.tb14384.x.CrossRefPubMed
28.
go back to reference Hutchinson WL, Noble GE, Hawkins PN, Pepys MB: The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest. 1994, 94 (4): 1390-1396. 10.1172/JCI117474.CrossRefPubMedPubMedCentral Hutchinson WL, Noble GE, Hawkins PN, Pepys MB: The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest. 1994, 94 (4): 1390-1396. 10.1172/JCI117474.CrossRefPubMedPubMedCentral
29.
go back to reference Register TC, Burdon KP, Lenchik L, Bowden DW, Hawkins GA, Nicklas BJ, Lohman K, Hsu FC, Langefeld CD, Carr JJ: Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. Clin Chem. 2004, 50 (11): 2185-2187. 10.1373/clinchem.2004.036806.CrossRefPubMed Register TC, Burdon KP, Lenchik L, Bowden DW, Hawkins GA, Nicklas BJ, Lohman K, Hsu FC, Langefeld CD, Carr JJ: Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. Clin Chem. 2004, 50 (11): 2185-2187. 10.1373/clinchem.2004.036806.CrossRefPubMed
30.
go back to reference Albert MA, Glynn RJ, Buring J, Ridker PM: C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004, 93 (10): 1238-1242. 10.1016/j.amjcard.2004.01.067.CrossRefPubMed Albert MA, Glynn RJ, Buring J, Ridker PM: C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004, 93 (10): 1238-1242. 10.1016/j.amjcard.2004.01.067.CrossRefPubMed
31.
go back to reference Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004, 15 (12): 3184-3191. 10.1097/01.ASN.0000146422.45434.35.CrossRefPubMed Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A: Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004, 15 (12): 3184-3191. 10.1097/01.ASN.0000146422.45434.35.CrossRefPubMed
32.
go back to reference Schutte AE, van Vuuren D, van Rooyen JM, Huisman HW, Schutte R, Malan L, Malan NT: Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study. J Hum Hypertens. 2006, 20 (11): 850-859. 10.1038/sj.jhh.1002065.CrossRefPubMed Schutte AE, van Vuuren D, van Rooyen JM, Huisman HW, Schutte R, Malan L, Malan NT: Inflammation, obesity and cardiovascular function in African and Caucasian women from South Africa: the POWIRS study. J Hum Hypertens. 2006, 20 (11): 850-859. 10.1038/sj.jhh.1002065.CrossRefPubMed
33.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, et al: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17 (10): 2937-2944. 10.1681/ASN.2006040368.CrossRefPubMed Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, et al: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17 (10): 2937-2944. 10.1681/ASN.2006040368.CrossRefPubMed
Metadata
Title
Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: A cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA)
Authors
Christopher Keller
Ronit Katz
Mary Cushman
Linda F Fried
Michael Shlipak
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2008
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-9-9

Other articles of this Issue 1/2008

BMC Nephrology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.